SMARCB1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1
Also known as: BAF47, hSNFS, INI-1, Ini1, PPP1R144, RDT, Sfh1p, SNF5, SNF5_HUMAN, SNF5L1, Snr1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12824
- Gene
- SMARCB1
- Ensembl
- ENSG00000099956
- Chromosome
- 22
- Canonical length
- 385 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center
OverviewNCBI Gene
The protein encoded by this gene is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively. The encoded nuclear protein may also bind to and enhance the DNA joining activity of HIV-1 integrase. This gene has been found to be a tumor suppressor, and mutations in it have been associated with malignant rhabdoid tumors. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
385 residues, UniProt reviewed canonical sequence.
>Q12824|SMARCB1
1 MMMMALSKTF GQKPVKFQLE DDGEFYMIGS EVGNYLRMFR GSLYKRYPSL WRRLATVEER
61 KKIVASSHGK KTKPNTKDHG YTTLATSVTL LKASEVEEIL DGNDEKYKAV SISTEPPTYL
121 REQKAKRNSQ WVPTLPNSSH HLDAVPCSTT INRNRMGRDK KRTFPLCFDD HDPAVIHENA
181 SQPEVLVPIR LDMEIDGQKL RDAFTWNMNE KLMTPEMFSE ILCDDLDLNP LTFVPAIASA
241 IRQQIESYPT DSILEDQSDQ RVIIKLNIHV GNISLVDQFE WDMSEKENSP EKFALKLCSE
301 LGLGGEFVTT IAYSIRGQLS WHQKTYAFSE NPLPTVEIAI RNTGDADQWC PLLETLTDAE
361 MEKKIRDQDR NTRRMRRLAN TAPAWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SMARCB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 78 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 78 nTPM
- ovary: 65 nTPM
- testis: 62 nTPM
- cervix: 56 nTPM
- skeletal muscle: 54 nTPM
- endometrium: 53 nTPM
Single-cell type
- oocytes: 83 nCPM
- choroid plexus epithelial cells: 48 nCPM
- proximal tubule cells: 42 nCPM
- late primary spermatocytes: 42 nCPM
- renal collecting duct intercalated cells: 40 nCPM
- undifferentiated spermatogonia: 40 nCPM
Immune cell
- memory B-cell: 25 nTPM
- non-classical monocyte: 17 nTPM
- intermediate monocyte: 13 nTPM
- plasmacytoid DC: 13 nTPM
- classical monocyte: 13 nTPM
- myeloid DC: 12 nTPM
Brain region
- cerebral cortex: 14 nTPM
- medulla oblongata: 9.9 nTPM
- cerebellum: 9.5 nTPM
- choroid plexus: 6.5 nTPM
- midbrain: 6.4 nTPM
- white matter: 6.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SMARCB1.
Disease | AllUniProt
Conditions SMARCB1 is implicated in, by any mechanism.
- Rhabdoid tumor predisposition syndrome 1 (RTPS1) MIM:609322
- Schwannomatosis 1 (SWN1) MIM:162091
- Coffin-Siris syndrome 3 (CSS3) MIM:614608
Disease | GeneticClinVar
121 pathogenic / likely-pathogenic of 1,348 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hereditary cancer-predisposing syndrome
- Rhabdoid tumor predisposition syndrome 1
- Intellectual disability, autosomal dominant 15
- SMARCB1-related schwannomatosis
- Coffin-Siris syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.6
- DepMap mean gene effect
- -0.82
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blastocyst hatching
- chromatin remodeling
- DNA integration
- hepatocyte differentiation
- host-mediated activation of viral transcription
- negative regulation of cell population proliferation
- nervous system development
- nucleosome disassembly
- positive regulation of cell differentiation
- positive regulation of double-strand break repair
- positive regulation of glucose mediated signaling pathway
- positive regulation of myoblast differentiation
- positive regulation of stem cell population maintenance
- positive regulation of T cell differentiation
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription of nucleolar large rRNA by RNA polymerase I
- regulation of G0 to G1 transition
- regulation of G1/S transition of mitotic cell cycle
- regulation of mitotic metaphase/anaphase transition
- regulation of nucleotide-excision repair
- regulation of transcription by RNA polymerase II
- RNA polymerase I preinitiation complex assembly
- transcription initiation-coupled chromatin remodeling
- single stranded viral RNA replication via double stranded DNA intermediate
Molecular functions
- DNA binding
- identical protein binding
- p53 binding
- Tat protein binding
- transcription coactivator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SNF5/SMARCB1/INI1
- Chromatin-remodeling complex component Sfh1/SNF5
- SWI/SNF Subunit INI1, DNA binding domain
- SNF5 / SMARCB1 / INI1
- SWI/SNF Subunit INI1, DNA binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SMARCB1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SMARCB1 as an antibody target. Whether an autoantibody or antibody against SMARCB1 could matter depends on whether native SMARCB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SMARCB1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SMARCB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...